MENU
IRD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Opus Genetics (IRD) Ownership - Who owns Opus Genetics?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.78M
P/E Ratio
N/A
Total Cash
36.64M
Projected Growth
N/A
Total Debt
N/A
Revenue
8.38M
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
1.16
Total Debt/Equity
N/A
Revenue/Share
0.34 USD as % of share price
Fundamentals
IRD
Capitalization
28.8M
P/E Ratio
N/A
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash
36.6M
Total Cash/Share
1.16
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.34%
Revenue
8.38M
ROE
N/A
Book Value
34.3M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
6.63
Current Revenue Per Employee
276214.28
Dividends Per Share - Security
N/A
EBITDA
-28.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-57.50
Shares Held By Institutions
5.35M
Shares Outstanding - Current
31.6M
Total Liabilities
6.09M
Total Volume MTD
N/A
Value
1
Gain YTD
-69.714
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics
Industry Biotechnology
Profile
Fundamentals
Details